the invention relates to medicine, specifically to the pharmacy, \u0438\u043d\u0444\u0435\u043a\u0442\u043e\u043b\u043e\u0433\u0438\u0438 and biotechnology, and is intended for the treatment of infectious diseases of man and animals, time i suppress the virulence of bacteria, as well as in biotechnology to enhance the building of biomass of microorganisms in the production of \u043f\u0440\u043e\u0431\u0438\u043e\u0442\u0438\u043a\u043e\u0432, lactic acid \u0437\u0430\u043a\u0432\u0430 juice, \u0432\u0430\u043a\u0446\u0438\u043d\u043d\u043e\u043c production, alcohol and \u0434\u0440\u043e\u0436\u0436\u0435\u0432\u043e\u043c productions.on the basis of the invention is to develop a \u0430\u043a\u0442\u0438\u0432\u0430\u0442\u043e\u0440\u044b growth of micro-organisms, does not contain heavy metals, non-toxic to humans and animals, the region \u0430\u0434\u0430\u044e\u0449\u0438\u0435 \u043c\u0443\u0442\u0430\u0433\u0435\u043d\u043d\u044b\u043c and carcinogenic effects and enhance the growth of microbial cells in 2 or more times.with the ability to suppress the virulence of microorganisms with the opportunity to use the properties in the treatment of infectious diseases in humans and animals, through the use of \u044d\u043d\u0445\u0430\u043d\u0441\u0435\u0440\u043e\u0432 before the course \u043f\u0440\u043e\u0442\u0438\u0432\u043e\u043c\u0438\u043a\u0440\u043e\u0431\u043d\u043e\u0439 therapy.the task is solved by adding in a permissive environment for the cultivation of microorganisms, growth of microorganisms of the inducer \u0430\u043a\u0442\u0438\u0432\u0430\u0442\u043e\u0440\u043e\u0432 mixture s of the cyclical \u0430\u0434\u0435\u043d\u043e\u0437\u0438\u043d\u043c\u043e\u043d\u043e\u0444\u043e\u0441\u0444\u0430\u0442\u0430 with proven \u0431\u0435\u0437\u0432\u0440\u0435\u0434\u043d\u043e\u0441\u0442\u044c\u044e for human body, which leads to the acceleration of the first colonies and stole \u0438\u0447\u0435\u043d\u0438\u044e growth of microbial cells in 2 - 4 t
